Prevention of Ischemic Myocardial Contracture Through Hemodynamically Controlled DCD

Area of Science:

• Cardiology
• Transplantation Medicine
• Medical Devices

Background:

• Ischemic myocardial contracture (IMC), or "stone heart," is a rapid post-mortem condition that prevents heart transplantation from donors after circulatory death (DCD).
• Preserving DCD hearts for transplantation is crucial to meet the growing demand for donor organs.

Purpose of the Study:

• To investigate the effectiveness of hemodynamic normalization after withdrawal of life-sustaining therapy (WLST) in preventing IMC.
• To test the hypothesis that reducing cardiac work delays IMC onset in a DCD model.

Main Methods:

• A large-animal DCD model was used, with a control group receiving no therapy and a test group receiving automated, computer-controlled hemodynamic drug administration.
• The primary endpoint was the onset of IMC within 1 hour following circulatory death.
• Cardiac work was estimated using pressure-volume loop concepts to assess therapeutic efficacy.

Main Results:

• None of the test group subjects developed IMC within the observed period.
• All control group subjects developed IMC within the observed period (4/6 within 1 hour).

Conclusions:

• Automated hemodynamic drug delivery in DCD models can prevent IMC for extended periods, facilitating ethical organ procurement.
• This approach has the potential to significantly increase the utilization of DCD hearts for transplantation.